scholarly article | Q13442814 |
P356 | DOI | 10.1002/PHAR.1760 |
P8608 | Fatcat ID | release_akaiitosijaj3ctw4fc45s5f4q |
P698 | PubMed publication ID | 27130442 |
P50 | author | Daniel Brodie | Q87827918 |
Matthew D. Bacchetta | Q91549093 | ||
P2093 | author name string | Robin Ruthazer | |
John W Devlin | |||
Amy L Dzierba | |||
Caroline Der Nigoghossian | |||
Justin Muir | |||
Greg Schumaker | |||
Russel Roberts | |||
Joshua Etheridge | |||
P2860 | cites work | APACHE II: a severity of disease classification system | Q29547729 |
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. | Q30381573 | ||
Sedation and analgesia usage in severe pandemic H1N1 (2009) infection: a comparison to respiratory failure secondary to other infectious pneumonias | Q30410665 | ||
Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis. | Q30817425 | ||
Neuromuscular blockers in early acute respiratory distress syndrome | Q34023977 | ||
Intensive Care Delirium Screening Checklist: evaluation of a new screening tool | Q34082486 | ||
Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort study | Q34468933 | ||
Propofol infusion syndrome. | Q34637170 | ||
The association between acute respiratory distress syndrome, delirium, and in-hospital mortality in intensive care unit patients | Q34987134 | ||
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial | Q35003693 | ||
Opioid conversions in acute care | Q36735197 | ||
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation | Q36928231 | ||
Review of a large clinical series: sedation and analgesia usage with airway pressure release and assist-control ventilation for acute lung injury. | Q37275016 | ||
Extracorporeal membrane oxygenation for ARDS in adults | Q37956671 | ||
The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashion | Q38132576 | ||
Extracorporeal life support for adults with severe acute respiratory failure. | Q38185815 | ||
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial | Q38383872 | ||
The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients | Q39635309 | ||
Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics | Q40955466 | ||
Use of ECMO in the Management of Severe Acute Respiratory Distress Syndrome: A Survey of Academic Medical Centers in the United States | Q41010765 | ||
Prolonged sedation due to accumulation of conjugated metabolites of midazolam | Q42276898 | ||
Determinants of drug absorption in different ECMO circuits. | Q42362818 | ||
Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions | Q43240250 | ||
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). | Q44473697 | ||
Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients | Q46721363 | ||
Sedative clearance during extracorporeal membrane oxygenation | Q46857795 | ||
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. | Q48092301 | ||
Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center | Q48230012 | ||
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. | Q50798434 | ||
In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. | Q51417979 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | acute respiratory distress syndrome | Q344873 |
sedative | Q847705 | ||
extracorporeal membrane oxygenation | Q1385195 | ||
P304 | page(s) | 607-616 | |
P577 | publication date | 2016-04-30 | |
P1433 | published in | Pharmacotherapy | Q7180800 |
P1476 | title | Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome | |
P478 | volume | 36 |
Q39033001 | Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation |
Q47376514 | Ketamine use in sedation management in patients receiving extracorporeal membrane oxygenation |
Q39023540 | Limiting sedation for patients with acute respiratory distress syndrome - time to wake up. |
Q39188586 | Medicating patients during extracorporeal membrane oxygenation: the evidence is building |
Q55393633 | Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. |
Q64122290 | The Use of Volatile Anesthetics as Sedatives for Acute Respiratory Distress Syndrome |
Search more.